Summer is a great time to slow down and actually learn something new. The GLP-1 space is full of influencers, making it hard to separate solid information from hype. That's why I put together this list of scientifically grounded videos. Whether you're just starting therapy or have been on GLP-1s for a while, I think you'll find many practical insights that can help you make more informed decisions about your own treatment.

In this deep dive, neuroscientist Dr. Zachary Knight explains what weight loss medications are actually doing inside the brain. It provides one of the best explanations of food noise and breaks down how GLP-1 medications influence dopamine pathways, hunger centres and cravings. If you've ever wondered why you suddenly stopped craving sugar, alcohol or certain foods after starting treatment, this video gives a fascinating scientific explanation.

I recommend this interview because it covers many of the everyday challenges people face, including preserving muscle, dealing with constipation, managing expectations, and understanding why losing weight too quickly isn't always the best approach. It's a thoughtful conversation full of practical tips. Nothing sensational, just honest advice and helpful information you can actually apply.

Plateaus are one of the most challenging parts of weight loss and almost everyone experiences them at some point. This video is another excellent, practical resource from a practicing physician and obesity specialist who understands the realities of long-term treatment. One of the biggest takeaways is that a plateau doesn't automatically mean something is wrong or that you simply need a higher dose.

Really enjoyed this conversation with Dr. Wharton about the future of GLP-1 treatments, especially the deep dive into the OASIS-4 and ATTAIN-1 trials looking at oral semaglutide (Wegovy pill) and orforglipron. Dr. Wharton brings a unique perspective as both a PharmD and a lead investigator involved in these studies. He explains the science behind the trials - how researchers decide on dosing, why taking a GLP-1 orally is a completely different challenge than using injections and what factors determine whether a new medication can succeed.

One of the most interesting parts is hearing about the differences between promising oral GLP-1 candidates and earlier attempts that didn't reach the finish line, and why developing an effective pill requires solving many complex problems.

This episode is worth a listen if you want to understand the bigger picture beyond GLP-1 weight loss. It takes a broader look at the rapidly evolving peptide landscape, covering compounds like BPC-157 or retatrutide.

I found it especially useful because it puts GLP-1 medications into the context of the wider peptide field and explains how this space is developing. A good overview for anyone who wants to stay informed about where the science and industry may be heading next.

Support this newsletter.

Send a coffee my way

A small contribution makes a big difference. Thank you!